Article
The emerging role of pharmacogenomics in biologics.
Clinical pharmacology and therapeutics - 1 Oct 2007
Lacaná E, Amur S, Mummanneni P, Zhao H, Frueh F W
Abstract excerpt
Biologics can be seen as "designer" drugs whose mode of action in a specific disease mechanism is frequently well understood, making it often possible to predict better efficacy and safety profiles for biologics when compared with small molecule drugs. Biologics have been approved for the treatment of major disease classes, such as inflammatory disease, cardiovascular disease, and cancer. However, as it is true...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.